# US 2015/0174208 A1 · Cosmetic and pharmaceutical composition with modified olygopeptides in form of supramolecular assembly

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0174208 A1
- Document ID: US20150174208A1
- Status: Published application
- Kind: A1
- Application number: 14/140,489
- Filed: 2013-12-25
- Published: 2015-06-25
- Earliest claimed: 2013-12-25
- Inventors: Artur Martynov; Boris S. Farber; Sonya Sophya Farber
- Web page: https://patentgrep.com/patent/US20150174208A1

## CPC

- A61K 38/28: Insulins
- A61K 8/64: Proteins; Peptides; Derivatives or degradation products thereof
- A61K 8/66: Enzymes
- A61K 38/01: Hydrolysed proteins; Derivatives thereof
- A61K 38/47: acting on glycosyl compounds (3.2), e.g. cellulases, lactases
- A61K 38/4886: {Metalloendopeptidases (3.4.24), e.g. collagenase}
- A61Q 19/00: Preparations for care of the skin
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The invention is a cosmetic and pharmaceutical liposomal composition which comprises a mixture of carboxylated oligopeptides derived from natural polypeptides; insulin; hyaluronidase and collagenase by their enzymatic hydrolysis; followed by a carboxylation of the free amino groups of lysine, histidine, and additional hydrolysis of terminal amino groups in the oligopeptides. Natural polypeptides may be hydrolyzed with a proteolytic enzyme to form a mixture of oligopeptides and succinylated them. Next, the resulting mixture was injected into the liposomes by classical methods to improve the intestinal absorption and bioavailability in the body, prolonging the action of the system. Such a system behaves as quasi-live and is capable of forming supramolecular complexes with the original proteins, such as insulin and acylated insulin oligopeptides, or insulin receptors on a cell and acylated insulin's oligopeptides. These cosmetic formulations may be used as prophylactic and therapeutic drugs in the prevention of infectious diseases as do vaccines in the treatment of cancer; pancreatitis and other diseases; rejuvenation of skin and body; and acceleration of wound healing.

## Claims

### Claim 1

A cosmetic or pharmaceutical composition comprising liposomes with a mixture of succinylated oligopeptides in the form of a supramolecular assembly, wherein the succinylated oligopeptides are obtained by enzymatic hydrolysis of natural polypeptides, wherein the natural polypeptides are selected from a mixture of collagenase, hyaluronidase and insulin, which results in an oligopeptide mixture ranging from 2 to 30 amino acid residues; afterwards succinylation of amino acid residues having a free amino groups in the oligopeptide mixture is done by partially acylating the mixture, the oligopeptides are acylated at a modification level of 0.1 to 10% of their mass.

### Claim 2

(canceled)

### Claim 3 (depends on 1)

The composition according to claim 1, wherein the liposomes are obtained by a reverse phase method, followed by an ultrasound processing of the liposomes.

### Claim 4 (depends on 1)

The composition according to claim 1, wherein the liposomes are obtained by the freezing-thawing method.

### Claim 5 (depends on 1)

The composition according to claim 1, wherein the liposomes are obtained by a method of introducing the protein solution to a suspension of lyophilized liposomes.

### Claim 6 (depends on 1)

The composition according to claim 1, wherein the liposomes are derived from phosphatidylcholine.

### Claim 7 (depends on 1)

The composition according to claim 1, wherein the liposomes are derived from phosphatidylethanolamine.

### Claim 8 (depends on 1)

The composition according to claim 1, wherein the liposomes are derived from a mixture of phosphatidylcholine and phosphatidylethanolamine.

### Claim 9

A method of obtaining a cosmetic and pharmaceutical composition comprising liposomes with a mixture of carboxylated oligopeptides, obtained by enzymatic hydrolysis of natural polypeptides, that resulted in a oligopeptide mixture ranging of 2 to 30 amino acid residues, and carboxylation of amino acid residues having a free amino groups in the oligopeptide mixture by acylating with succinic anhydride or alkylating with monochloroacetic acid, wherein the oligopeptides are acylated at modification level of 0.1 to 10% of their mass and are present in the form of a supramolecular assembly, wherein the proteins are derived from an at least one of collagenase, hyaluronidase, and insulin.

### Claim 10 (depends on 13)

The method according to claim 13, wherein the partially acylated protein is hyaluronidase.

### Claim 11 (depends on 13)

The method according to claim 13, wherein the partially acylated protein is collagenase.

### Claim 12 (depends on 13)

The method according to claim 13, wherein the partially acylated protein is insulin.

### Claim 13 (depends on 13)

The method according to claim 13, wherein the partially acylated protein is a mixture of collagenase, hyaluronidase, and insulin.

### Claim 14 (depends on 13)

The method according to claim 13 wherein the partially acylated proteins are produced via a reaction with succinic anhydride.

### Claim 15 (depends on 13)

The method according to claim 13, wherein the liposomes are obtained by a reverse phase method, followed by an ultrasound treatment of the liposomes.

### Claim 16 (depends on 13)

The method according to claim 13, wherein the liposomes are obtained by freezing-thawing.

### Claim 17 (depends on 13)

The method according to claim 13, wherein the liposomes are obtained by introducing a protein solution into a suspension of lyophilized liposomes.

### Claim 18 (depends on 13)

The method according to claim 13, wherein the liposomes are derived from phosphatidylcholine.

### Claim 19 (depends on 13)

The method according to claim 13, wherein the liposomes are derived from phosphatidylethanolamine.

### Claim 20 (depends on 13)

The method according to claim 13, wherein the liposomes are derived from a mixture of phosphatidylcholine and phosphatidylethanolamine.
